Objective: Respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) are frequent complications of prematurity. To decrease ventilator-induced lung injury, we evaluated the safety, efficacy and neonatal outcomes of a heated humidified high-flow nasal cannula (HFNC) system and an early extubation protocol (EEP) designed for preterm infants 25 to 29 weeks' gestational age (GA). Result: Inclusion criteria were met by 49/57 infants in the control group and 65/75 infants in the HFNC group. The groups had similar demographics, perinatal conditions, birthweight, GA, timing and total doses of surfactant. There were no differences in rates of extubation failure, patent ductus arteriosus, intraventricular hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, laser eye surgery, sepsis, BPD at 28 days and 36 weeks and death. The groups did not differ in oxygen use, i.v. steroid days, or parenteral nutrition days. Days to reach full feeds were similar. Infants in the HFNC group were extubated from a higher ventilator rate (32.6±8.5 vs 28±7.5, P ¼ 0.003) and spent fewer days on the ventilator (11.4±12.8 vs 18.5±21, P ¼ 0.028). Rates of ventilatorassociated pneumonia were higher in the control group (P ¼ 0.018). Discharge weights were greater in the HFNC group (P ¼ 0.016) despite similar length of stay and GA at discharge.
Introduction
Despite the availability of antenatal glucocorticoid therapy and surfactant-replacement therapy, respiratory distress syndrome (RDS) and its sequela, bronchopulmonary dysplasia (BPD) are both common complications in very low birthweight infants. In an effort to decrease ventilator-induced lung injury, many centers have implemented a less invasive approach to ventilation. This includes the use of nasal continuous positive airway pressure (NCPAP), and more recently a heated high-flow humidified nasal cannula (HFNC) system.
The Vapotherm (VT) 2000i (Vapotherm Inc., Stevensville, MD, USA) high-flow humidification system is a relatively new mode of respiratory support that delivers high-flow gas heated with nearly 100% humidity, allowing higher flows (1 to 8 l min À1 using the pediatric cartridge) to be tolerated by the patient. 1 Despite its widespread use in many neonatal intensive care units (NICUs), this device has not been rigorously studied in the infant population.
Recently, Saslow et al. 2 and Woodhead et al. 3 report that HFNC provides respiratory support comparable to continuous positive airway pressure (CPAP) and that infants are less likely to fail extubation when compared with standard HFNC. While these two small, randomized trials provide important objective data regarding HFNC therapy with VT, they do not address outcomes such as duration of supplemental oxygen, rates of BPD and length of hospital stay. Shoemaker et al. 4 describe their recent experience with HFNC in a retrospective study and found HFNC to be well tolerated with no apparent differences in adverse outcomes when compared to the infants managed with NCPAP. Additional research though is still needed to support the utility and safety of this widely accepted form of non-invasive respiratory support.
The implementation of medical management protocols to provide consistent and efficient medical care is increasing in all areas of medicine. While a protocol is in place in our unit for practices such as parenteral nutrition administration, initiation and advancement of enteral feeds and evaluation and treatment of hyperbilirubinemia, a protocol for the management of our very low birth infants with RDS had never been developed.
The purpose of this study was to evaluate the safety, efficacy and neonatal outcomes of a heated humidified HFNC system and an early extubation protocol (EEP) designed for premature infants 25 to 29 weeks of gestational age. These results were compared to previous outcomes when non-invasive respiratory support consisted primarily of NCPAP.
Methods

Subjects
Vapotherm was introduced to the Loyola University Medical Center NICU in March 2004. After 10 months of use, an EEP ( Figure 1 ) was developed to begin January 2005. By that time, our staff had become comfortable using VT and developed a preference for VT over NCPAP when CPAP was desired. We subsequently performed a quality improvement study evaluating the safety and efficacy of VT. The study group (HFNC group) included infants 25 to 29 weeks of gestational age, admitted January to December 2005, and intubated for RDS. Outborn infants were allowed to participate if transferred to Loyola within 12 h of life. Infants admitted January to December 2003, prior to the use of VT, served as the historical control group. Exclusion criteria in both groups were: major congenital anomalies, asphyxia and a 5 min Apgar score <5.
Management of RDS
Infants who were intubated in the delivery room remained intubated until they were reassessed in the NICU. The extubation criteria shown in the EEP were absolute numbers agreed upon by the neonatal fellows, neonatal attendings and head of respiratory therapy. If all the criteria were met, the infant would receive a trial of extubation. Extubation from higher ventilator settings was allowed at the discretion of the clinician. The EEP criteria for carbon dioxide and pH criteria were the same for arterial, venous or capillary sources. The fraction of inspired oxygen (FiO 2 ) while on the ventilator or VT was adjusted to provide target saturation criteria of 85 to 92% for infants less than 28 weeks' gestation and 90 to 95% for infants 28 to 29 weeks' gestation. Infants were extubated to the VT 2000i (Vapotherm Inc. Stevensville) at flows of 4 to 6 l min À1 . Flow rates and FiO 2 were adjusted by the clinician to provide enough distending pressure to minimize work of breathing and optimize blood gas results and oxygen saturation levels. Lung expansion was not followed by chest radiographs once an infant was extubated.
It was at the discretion of the clinician to decide either by clinical and/or laboratory criteria if an infant was failing extubation. Criteria considered included increased respiratory effort, deteriorating blood gases, rising FiO 2 requirement and increasing apnea and bradycardia requiring frequent bag/mask breaths. Any future attempts at extubation, once a patient was re-intubated, was at the discretion of the clinician and not per the EEP.
Infants in the retrospective cohort (historical control group) were extubated to CPAP (Sechrist Infant Ventilator, IV-100B) at a pressure of 8 cm H 2 O, standard flow nasal cannula at flow rates up to 2 l min À1 , or room air depending on clinical exam, ventilator support prior to extubation, blood gas analysis and FiO 2 requirement. Although an EEP was not in place during this period, permissive hypercapnia was tolerated with a goal of maintaining a pH X7.25. Target oxygen saturation criteria were the same as those in the HFNC group.
Data collected
Demographic data including maternal history, route of delivery, birthweight GA, gender and Apgar scores were collected on all infants. All adverse outcomes were documented until discharge or death. This included: pneumothorax, pulmonary hemorrhage, BPD, late-onset sepsis, ventilator-associated pneumonia, patent ductus arteriosus (PDA), intraventricular hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, retinopathy of prematurity requiring laser photocoagulation and death. Chorioamnionitis was defined by the presence of a positive culture from the amniotic fluid or inflammation of the amnion and chorion on microscopic examination of the placenta. An infant was given the diagnosis of RDS in the presence of respiratory distress and a characteristic reticular granular pattern with air bronchograms on chest radiographs. Respiratory support days were defined as days spent on a ventilator, CPAP device or nasal cannula device. A pneumothorax was defined using radiographic evidence of an air leak around the lungs. Pulmonary hemorrhage was defined as the presence of blood in the endotracheal tube associated with a rapid deterioration in the patient's respiratory status. Intravenous steroid use was defined as Dexamethasone 0.3 to 0.5 mg kg À1 day À1 for five to seven days for BPD; other corticosteroid use was not included. Figure 1 Early extubation protocol. Abbreviations: DR, delivery room; GA, gestational age; PIP, peak inspiratory pressure.
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All infants in both groups were started on parenteral nutrition within the first 24 h of life, with dextrose, amino acids and lipids. Glucose infusion rates were begun at 4 to 7 mg kg À1 min À1 and increased daily as tolerated by 1 to 2 mg kg À1 min À1 until a goal of 10 to 12 mg kg À1 min À1 was achieved. Amino-acid solutions were started at 2.5 to 3 g kg À1 day À1 and increased daily by 0.5 g kg À1 day À1 until a maximum of 3.5 g kg À1 day À1 was achieved. Lipids were begun at 0.5 to 1 g kg À1 day À1 and increased daily as tolerated by 0.5 g kg À1 day À1 until a maximum of 3.5 g kg À1 day À1 was achieved. Total fluid volumes were increased daily until a goal of 140 to 160 ml kg À1 day À1 was achieved during the first week of life. Infants were started on trophic feeds when clinically stable. Enteral nutrition was increased by 10 to 20% every day as tolerated until a goal of 150 ml kg À1 day À1 of 24 cal formula was achieved. Full feeds were defined as 120 kcal kg À1 day À1 of enteral nutrition. All infants had cranial ultrasounds performed at days 7 and 28 of age. These were used to diagnose IVH according to Papile's method of classification. 5 Periventricular leukomalacia was diagnosed when cystic lesions were present in the periventricular white matter on cerebral ultrasound, computerized tomography scan or magnetic resonance imaging. 6 Late-onset sepsis was defined as a positive blood culture in a sick infant occurring after the first 72 h of life. Ventilator-associated pneumonia was defined as a positive tracheal aspirate culture with many white blood cells on microscopy, together with clinically significant deterioration in the infant's respiratory status while on the ventilator, as determined by the clinician. BPD was defined as the need for supplemental oxygen at X28 days and 36 weeks postmenstrual age. Necrotizing enterocolitis was defined as Xstage-2 modified Bell's criteria. 7 Infants were examined by pediatric ophthalmologists at 4 weeks of age with examinations repeated every 1 to 2 weeks as indicated. Retinopathy of prematurity was diagnosed using the international classification system. 8 PDA diagnosis was made after an echocardiogram with Doppler flow documented the presence of a PDA. Pediatric cardiologists made a recommendation for indomethacin therapy based on significance of flow.
Statistics
Demographics, pulmonary outcomes, NICU course and all other adverse outcomes were compared between the two group using Student's t-test, w 2 and Mann-Whitney U as appropriate. A P-value of <0.05 was considered statistically significant. This study was approved by the Institutional Review Board.
Results
Inclusion criteria were met by 49/57 infants in the control group and 65/75 infants in HFNC group. Five infants were excluded in the control group because of low Apgar scores (n ¼ 3) and multiple congenital anomalies (n ¼ 2). Three infants were never intubated.
Eight infants in the HFNC group were excluded because of low Apgar scores (n ¼ 7) and multiple congenital anomalies (n ¼ 1). Two infants were never intubated. There were no significant differences between the two groups with regard to maternal age, maternal race, prenatal steroid administration, route of delivery, GA, birthweight, gender and Apgar scores (Table 1) . A small but similar number of infants in both groups were transferred from an outside hospital within the first 12 h of life.
The early extubation protocol was followed 82.8% of the time (53/64) in the HFNC group. Six infants were on minimal ventilator settings and not extubated even though extubation criteria were met. All six infants were being treated with indomethacin for a PDA and not extubated until after the treatment was complete. Only two of the six infants appeared to have a symptomatic PDA and had recorded bradycardic episodes or desaturations. These six infants were not extubated secondary to attending discretion while being treated for a PDA. Five other infants were not extubated when criteria were met secondary to bradycardia and/or desaturation. Nineteen infants were extubated from higher settings than those established in the protocol (peak inspiratory pressures of 17 to 18 cm H 2 O and/or rates 40 to 60 breaths per minute). Only three of those nineteen infants failed extubation. All infants (64/64) were extubated to VT, 4 to 6 l min À1 . A total of eight infants (8/64, 12.5%) in the VT group failed extubation (four with increased work of breathing, three with apnea and one with a spontaneous intestinal perforation that occurred while being treated with indomethacin).
In the historical control group, 53.2% (25/47) were extubated to NCPAP þ 8 cm H 2 O, 38.3% (18/47) were extubated to nasal cannula at 1 to 2 l min À1 , and 8.5% (4/47) were extubated to room air. Seven infants (14.5%) failed extubation (three with apnea and four with increased work of breathing).
Pulmonary outcomes are presented in Table 2 . Although there was no difference in the peak inspiratory pressure at extubation, Heated humidified high-flow nasal cannula D Holleman-Duray et al infants in the HFNC group were extubated from a higher ventilator rate (32.6±8.5 vs 28±7.5, P ¼ 0.003). Infants in the HFNC group also spent fewer days on the ventilator (11.4±12.8 vs 18.5±21, P ¼ 0.028). This did not result in significantly less intravenous steroid use, respiratory support days, supplemental oxygen days or BPD at 28 days and 36 weeks' postmenstrual age. In the control group, one pneumothorax occurred while on the ventilator in a patient with congenital candidiasis. One pulmonary hemorrhage occurred in an infant on a ventilator in the HFNC group. A similar number of infants in both groups were discharged home on oxygen, diuretics, oral steroids and inhaled steroids. There were no differences between the groups in rates of blood transfusions, PDA, laser eye surgery, necrotizing enterocolitis, late onset sepsis, grade III or IV intraventricular hemorrhage or periventricular leukomalacia (Table 3) . Rates of ventilatorassociated pneumonia were higher in the control group (16.3 vs 3.1%, P ¼ 0.018). Days to reach full feeds and days spent on parenteral nutrition were similar between the two groups. Discharge weights were greater in the HFNC group (2758±499.1 vs 2493±621.9 g, P ¼ 0.016) despite similar length of stay and GA at discharge.
Three deaths occurred in the control group. In two instances, the infants died secondary to severe multi-organ failure after a protracted hospital course complicated by necrotizing enterocolitis and BPD. The other infant had congenital candidiasis and died in early infancy from respiratory failure. One death occurred in the HFNC group on the third day of life secondary to a catastrophic intraventricular hemorrhage. This infant was never extubated.
Discussion
Prolonged intubation in very low birthweight infants is associated with increased morbidity, including greater risk of infection and BPD. In an effort to decrease ventilator-induced lung injury, many centers support a noninvasive approach to ventilation using NCPAP as a primary mode of ventilation for RDS, with and without prophylactic surfactant, or as the modality of choice for extubation. NCPAP is effective in preventing extubation failure in preterm infants and avoiding the need for mechanical ventilation. [9] [10] [11] [12] However, its use has been limited in some infants by common complications of CPAP devices: nasal trauma, obstruction by secretions requiring frequent removal for suctioning, kinking of the nasopharyngeal prongs in the pharynx and overall perceived patient discomfort. 13, 14 Vapotherm is an HFNC system that prevents dryness of the nasal mucosa by warming and humidifying inhaled gas. 15 Despite its Calculations done with n ¼ 48 secondary to one death on day 13. f Calculations done with n ¼ 46 secondary to three deaths (on days 13, 120 and 211).
Heated humidified high-flow nasal cannula D Holleman-Duray et al lack of published randomized trials testing Vapotherm in a NICU setting, it is being used in many NICUs as an alternative to NCPAP. Potential reasons for its acceptance include its ease of use and perceived improved patient tolerance. Although the widespread acceptance of an unproven therapy is not new to neonatology, there are many who are hesitant to use VT until potential risks are investigated. Two major concerns still exist preventing the universal acceptance of the VT HFNC in the NICU: (1) the inability to measure the CPAP generated by VT, (2) the potential for infection. 16, 17 The unmeasured CPAP effect is a safety concern with the potential risk of lung over inflation, a known risk factor for BPD, as well as a cause of increased work of breathing. The potential for pneumothoraces is also a concern. Saslow et al.
2 estimated the airway end-distending pressures with the use of esophageal manometry and found no increase in work of breathing or end distending pressure when comparing NCPAP at 6 cm H 2 O with HFNC and 3, 4 and 5 l min
À1
. While we did not directly measure the CPAP generated in our infants on VT or perform serial chest radiographs, we concluded by our study results that infants do not appear at significant risk for pneumothoraces at flows up to 6 l min À1 . Although not quantified objectively, our infants did not appear clinically to have an increase in work of breathing. Further studies measuring the airway pressure generated using HFNC in this population need to be performed.
Anytime a water source is connected to a respiratory support device, or nasal cannulae or prongs are used capable of mucosal damage, there is potential for infection. Recently though, Woodhead et al. 3 found that VT performed better than standard HFNC in preserving a normal appearing nasal mucosa. One of our objectives was to investigate whether our infants extubated to HFNC were at any higher risk of bacterial sepsis than infants extubated previously to NPCPAP þ 8 cm H 2 O or NC at 1 to 2 l min À1 . Although Graham et al. 18 describe a significant association between nasal cannula CPAP use and Gram-negative bloodstream infections in very low birthweight infants, we did not have an increase in the overall incidence of late-onset sepsis or Gram-negative sepsis using the HFNC. We also demonstrated a decreased incidence in ventilator-associated pneumonia, an anticipated consequence of spending fewer days on the ventilator. While this provides us some reassurance, unresolved infection concerns need to be further investigated.
The EEP was designed to help our NICU staff become more comfortable in earlier extubation, as well as provide our patients with more consistent care. Prior to the initiation of our EEP, there was considerable variation in practice among our clinicians regarding extubation criteria. In addition to ventilator settings, other factors such as birthweight were considered when deciding whether an infant was ready for extubation. As we anticipated from anecdotal experience, a very small number of infants failed extubation and there were 16 infants who were successfully extubated from higher settings than those established in the protocol. As it became evident during the study that the majority of infants were successfully being extubated from the settings established in the protocol, clinicians became more comfortable attempting extubation from higher settings. While the infants in the HFNC group spent on average one week less on the ventilator, it is difficult to conclude if this is the result of our EEP and/or improved respiratory support provided by VT. Unfortunately, shorter ventilation time did not translate into significantly less respiratory support days, supplemental oxygen days, or BPD at 28 and 36 weeks of postmenstrual age. The failure to make an impact on the incidence of BPD despite decreasing the amount of time spent on the ventilator has been shown in previous studies evaluating NCPAP. 13, 19 Unexpectedly, we found improved growth of our infants in the HFNC group. Although we have maintained the same nutritionist, enteral feeding practices, and aggressive parenteral nutrition support in our unit over the entire period of the study, it is difficult to attribute this improvement solely to the HFNC without a prospective randomized study. Poor growth is frequently observed in infants with acute lung disease and BPD. Much of this is related to their abnormal pulmonary function and increased work of breathing. There is a correlation between the degree of respiratory compromise and oxygen consumption. 20 Subjectively, infants appear more comfortable using the HFNC. We speculate that the comfort and respiratory support provided by the HFNC may decrease energy demands resulting in improved growth. This needs to be evaluated in future trials.
We recognize various shortcomings of our study including its relatively small size and the comparison of prospectively collected data to historical controls. This study was underpowered to detect small differences in outcome, but the data suggest that large clinically significant differences are not likely. We conclude that this quality improvement study supports the role of HFNC with an EEP in decreasing ventilator days without an apparent increase in adverse outcomes. 
